Asklepion Pharmaceuticals Overview
- Founded
- 2006

- Status
- Private
- Employees
- 8

- Latest Deal Type
- Corporate
- Financing Rounds
- 1
Asklepion Pharmaceuticals General Information
Description
Operator of a pharmaceutical company engaged in the research and development. The company mainly focuses on different types of liver-based diseases.
Contact Information
- 729 East Pratt Street
- Suite 360
- Baltimore, MD 21202
- United States
Asklepion Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request a free trialAsklepion Pharmaceuticals Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Gary Pasternack Ph.D | Chief Executive Officer | ||
Kenneth Setchell Ph.D | Chief Scientific Officer | ||
Gary Pyner Sr. | Chief Commercial Officer |
Asklepion Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAsklepion Pharmaceuticals Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Asklepion Pharmaceuticals‘s full profile, request access.
Request a free trial